Making ICD Surgery Safer

(Ivanhoe Newswire) – A clinical trial coordinated by the University of Ottawa Heart Institute Cardiovascular Research Methods Centre has found that as compared to bridging therapy with heparin, continued warfarin treatment at the time of pacemaker or ICD surgery markedly reduced the incidence of clinically significant device-pocket hematoma, which was defined as device-pocket hematoma that prolonged hospitalization, interruption of anticoagulation therapy, or further surgery.
Source: Medical Headlines From Ivanhoe.com - Category: Consumer Health News Source Type: news